Physician

Kyle G Smith, D.O.

According to 2025 Medicare claims, Kyle Smith, D.O. (NPI: 1184663726) practices neuropsychiatry in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is EASTERSEALS MORC HEALTH CARE, INC. (NPI: 1376526616; TIN: 38-1402860) and primary practice location at 48034-1055.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 109 traditional Medicare patients, billed 399 HCPCS/CPT codes, and received $13,383 in Medicare payments. The top billing code was 99212 (Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more). Part D data shows 7,958 prescription claims across 215 beneficiaries totaling $1,458,830 in drug costs, led by Invega Sustenna (Paliperidone Palmitate). Open Payments data shows 25 records totaling $832. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $9,936 and ending at $13,383. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $313,470 to $1,458,830. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$18K$37K2015 Medicare payment: $9,936 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $15,773 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $32,581 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $23,829 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $34,443 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $31,395 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $36,700 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $22,538 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $19,554 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $13,383 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201552214$9,936
201675297$15,773
2017169666$32,581
2018224699$23,829
20193871,143$34,443
20203791,083$31,395
20213641,132$36,700
2022211760$22,538
2023111420$19,554
2024109399$13,383

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.0M2015 Drug cost: $313,470 (USD; Tot_Drug_Cst)2016 Drug cost: $232,100 (USD; Tot_Drug_Cst)2017 Drug cost: $388,183 (USD; Tot_Drug_Cst)2018 Drug cost: $667,198 (USD; Tot_Drug_Cst)2019 Drug cost: $1,379,069 (USD; Tot_Drug_Cst)2020 Drug cost: $1,466,549 (USD; Tot_Drug_Cst)2021 Drug cost: $2,022,545 (USD; Tot_Drug_Cst)2022 Drug cost: $1,931,787 (USD; Tot_Drug_Cst)2023 Drug cost: $1,448,108 (USD; Tot_Drug_Cst)2024 Drug cost: $1,458,830 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015921,805$313,470
2016981,840$232,100
20171824,354$388,183
20182977,302$667,198
201954716,122$1,379,069
202057015,272$1,466,549
202155418,727$2,022,545
202237414,355$1,931,787
20233138,448$1,448,108
20242157,958$1,458,830

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more109392$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Invega SustennaPaliperidone Palmitate1072,996$311,328
Austedo XrDeutetrabenazine381,118$250,944
RexultiBrexpiprazole772,228$148,577
AustedoDeutetrabenazine23691$145,837
Abilify MaintenaAripiprazole35980$84,639

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$832Teva Pharmaceuticals USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kyle G. Smith, D.O.?

Tedicare shows public-source Medicare data for Kyle G. Smith, D.O. (NPI 1184663726), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kyle G. Smith, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kyle G. Smith, D.O.?

Kyle G. Smith, D.O. is linked to EASTERSEALS MORC HEALTH CARE, INC. (billing NPI 1376526616) in the available physician profile data.

Does Kyle G. Smith, D.O. have Open Payments data?

Kyle G. Smith, D.O. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.